MedTrace Logo

AI-powered Chatbot vs. Human Counselors in Smoking Cessation

NCT06570070 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2024-08-26

No results posted yet for this study

Summary

This study aims to explore the feasibility and preliminary effectiveness of AI-powered chatbot support in community smokers.

Conditions

  • Smoking Cessation
  • Mobile Health

Interventions

BEHAVIORAL

5A's/5R's advice

5A's (Ask, Advise, Assess, Assist, Arrange) for smokers who are ready to quit, and 5R's (relevance, risks, rewards, roadblocks, and repetition) for smokers who are not ready to quit.

OTHER

Brief leaflet on health warning and smoking cessation

The contents of the leaflet include the absolute risk of smoking, diseases caused by active and second-hand smoking, horrible pictorial warnings of the health consequences of active and second-hand smoking, and the benefits of quitting.

OTHER

Self-help smoking cessation booklet

The contents include information about the benefits of quitting, methods to quit, how to handle withdrawal symptoms, misperceptions of quitting, etc.

BEHAVIORAL

AI-powered chatbot support

Participants will receive three months of AI-powered chatbot, equipped with personalized interactions and real-time support, via WeChat.

BEHAVIORAL

Counselor individual support

Participants will receive three months of counselor-led individual support via WeChat. The regular messages and instant messaging on psychosocial support aim to provide cessation advice, increase self-efficacy and confidence, and social support and behavioral capacity of quitting.

Sponsors & Collaborators

  • Beijing Normal University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-01
Primary Completion
2025-06-20
Completion
2025-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06570070 on ClinicalTrials.gov